Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment

R. D. Okada, W. D. Hager, P. E. Graves, Michael Mayersohn, D. G. Perrier, F. I. Marcus

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The purpose of this study was to determine if there is a linear relationship between oral doses of digoxin and various measurements of steady-state digoxin plasma concentration and urinary excretion in patients with a wide range of renal function. Ten patients (mean age 58 years) with creatinine clearances < 50 ml/min/1.73 m 2 BSA (mean creatinine clearance 80 ml/min/1.73 m 2 BSA) and nine patients (mean age 61 years) with creatinine clearances <50ml/min/1.73m 2 BSDA (mean creatinine clearance 20ml/min/1.73m 2 BSA) were given digoxin tablets orally at two or three different dose levels (dose range 0.0313-0.5 mg/day). After a dosing period equal to at least five half-lives, three to four consecutive daily digoxin plasma concentrations were determined. Plasma concentrations and urinary digoxin excretion were measured during one 24-hour dosing interval at each dose level. Digoxin plasma and urine concentrations were determined in triplicate using radioimmunoassay. Individual patient plots provided evidence of linearity for: digoxin 24-hour steady-state plasma concentration vs dose; digoxin 24-hour cumulative urinary excretion versus dose; and area under the digoxin plasma concentration-time curve during a 24-hour dosing interval vs dose. Absolute values for these various parameters indicated substantial interpatient variation probably due to patient differences in both digoxin absorption and digoxin total body clearance. These results indicate that there is a linear relationship between digoxin plasma concentration and dose in patients with normal and decreased real function. This linearity is support for dose-independent pharmacokinetics of digoxin in man. The authors conclude from these data that a change in digoxin dose should result in a proportional change in digoxin plasma concentration over the dose range examined.

Original languageEnglish (US)
Pages (from-to)1196-1203
Number of pages8
JournalCirculation
Volume58
Issue number6
StatePublished - 1978
Externally publishedYes

Fingerprint

Digoxin
Kidney
Creatinine
Tablets
Radioimmunoassay

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Okada, R. D., Hager, W. D., Graves, P. E., Mayersohn, M., Perrier, D. G., & Marcus, F. I. (1978). Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment. Circulation, 58(6), 1196-1203.

Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment. / Okada, R. D.; Hager, W. D.; Graves, P. E.; Mayersohn, Michael; Perrier, D. G.; Marcus, F. I.

In: Circulation, Vol. 58, No. 6, 1978, p. 1196-1203.

Research output: Contribution to journalArticle

Okada, RD, Hager, WD, Graves, PE, Mayersohn, M, Perrier, DG & Marcus, FI 1978, 'Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment', Circulation, vol. 58, no. 6, pp. 1196-1203.
Okada, R. D. ; Hager, W. D. ; Graves, P. E. ; Mayersohn, Michael ; Perrier, D. G. ; Marcus, F. I. / Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment. In: Circulation. 1978 ; Vol. 58, No. 6. pp. 1196-1203.
@article{3bb54d8593144082b55f642a4ff50c14,
title = "Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment",
abstract = "The purpose of this study was to determine if there is a linear relationship between oral doses of digoxin and various measurements of steady-state digoxin plasma concentration and urinary excretion in patients with a wide range of renal function. Ten patients (mean age 58 years) with creatinine clearances < 50 ml/min/1.73 m 2 BSA (mean creatinine clearance 80 ml/min/1.73 m 2 BSA) and nine patients (mean age 61 years) with creatinine clearances <50ml/min/1.73m 2 BSDA (mean creatinine clearance 20ml/min/1.73m 2 BSA) were given digoxin tablets orally at two or three different dose levels (dose range 0.0313-0.5 mg/day). After a dosing period equal to at least five half-lives, three to four consecutive daily digoxin plasma concentrations were determined. Plasma concentrations and urinary digoxin excretion were measured during one 24-hour dosing interval at each dose level. Digoxin plasma and urine concentrations were determined in triplicate using radioimmunoassay. Individual patient plots provided evidence of linearity for: digoxin 24-hour steady-state plasma concentration vs dose; digoxin 24-hour cumulative urinary excretion versus dose; and area under the digoxin plasma concentration-time curve during a 24-hour dosing interval vs dose. Absolute values for these various parameters indicated substantial interpatient variation probably due to patient differences in both digoxin absorption and digoxin total body clearance. These results indicate that there is a linear relationship between digoxin plasma concentration and dose in patients with normal and decreased real function. This linearity is support for dose-independent pharmacokinetics of digoxin in man. The authors conclude from these data that a change in digoxin dose should result in a proportional change in digoxin plasma concentration over the dose range examined.",
author = "Okada, {R. D.} and Hager, {W. D.} and Graves, {P. E.} and Michael Mayersohn and Perrier, {D. G.} and Marcus, {F. I.}",
year = "1978",
language = "English (US)",
volume = "58",
pages = "1196--1203",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment

AU - Okada, R. D.

AU - Hager, W. D.

AU - Graves, P. E.

AU - Mayersohn, Michael

AU - Perrier, D. G.

AU - Marcus, F. I.

PY - 1978

Y1 - 1978

N2 - The purpose of this study was to determine if there is a linear relationship between oral doses of digoxin and various measurements of steady-state digoxin plasma concentration and urinary excretion in patients with a wide range of renal function. Ten patients (mean age 58 years) with creatinine clearances < 50 ml/min/1.73 m 2 BSA (mean creatinine clearance 80 ml/min/1.73 m 2 BSA) and nine patients (mean age 61 years) with creatinine clearances <50ml/min/1.73m 2 BSDA (mean creatinine clearance 20ml/min/1.73m 2 BSA) were given digoxin tablets orally at two or three different dose levels (dose range 0.0313-0.5 mg/day). After a dosing period equal to at least five half-lives, three to four consecutive daily digoxin plasma concentrations were determined. Plasma concentrations and urinary digoxin excretion were measured during one 24-hour dosing interval at each dose level. Digoxin plasma and urine concentrations were determined in triplicate using radioimmunoassay. Individual patient plots provided evidence of linearity for: digoxin 24-hour steady-state plasma concentration vs dose; digoxin 24-hour cumulative urinary excretion versus dose; and area under the digoxin plasma concentration-time curve during a 24-hour dosing interval vs dose. Absolute values for these various parameters indicated substantial interpatient variation probably due to patient differences in both digoxin absorption and digoxin total body clearance. These results indicate that there is a linear relationship between digoxin plasma concentration and dose in patients with normal and decreased real function. This linearity is support for dose-independent pharmacokinetics of digoxin in man. The authors conclude from these data that a change in digoxin dose should result in a proportional change in digoxin plasma concentration over the dose range examined.

AB - The purpose of this study was to determine if there is a linear relationship between oral doses of digoxin and various measurements of steady-state digoxin plasma concentration and urinary excretion in patients with a wide range of renal function. Ten patients (mean age 58 years) with creatinine clearances < 50 ml/min/1.73 m 2 BSA (mean creatinine clearance 80 ml/min/1.73 m 2 BSA) and nine patients (mean age 61 years) with creatinine clearances <50ml/min/1.73m 2 BSDA (mean creatinine clearance 20ml/min/1.73m 2 BSA) were given digoxin tablets orally at two or three different dose levels (dose range 0.0313-0.5 mg/day). After a dosing period equal to at least five half-lives, three to four consecutive daily digoxin plasma concentrations were determined. Plasma concentrations and urinary digoxin excretion were measured during one 24-hour dosing interval at each dose level. Digoxin plasma and urine concentrations were determined in triplicate using radioimmunoassay. Individual patient plots provided evidence of linearity for: digoxin 24-hour steady-state plasma concentration vs dose; digoxin 24-hour cumulative urinary excretion versus dose; and area under the digoxin plasma concentration-time curve during a 24-hour dosing interval vs dose. Absolute values for these various parameters indicated substantial interpatient variation probably due to patient differences in both digoxin absorption and digoxin total body clearance. These results indicate that there is a linear relationship between digoxin plasma concentration and dose in patients with normal and decreased real function. This linearity is support for dose-independent pharmacokinetics of digoxin in man. The authors conclude from these data that a change in digoxin dose should result in a proportional change in digoxin plasma concentration over the dose range examined.

UR - http://www.scopus.com/inward/record.url?scp=0018218765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018218765&partnerID=8YFLogxK

M3 - Article

VL - 58

SP - 1196

EP - 1203

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 6

ER -